Nuvve Competitors

Nuvve (NASDAQ:NVVE) and Coupang (NYSE:CPNG) are both consumer cyclical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, earnings, profitability and institutional ownership.

Analyst Recommendations

This is a summary of recent ratings for Nuvve and Coupang, as provided by MarketBeat.com.

Nuvve currently has a consensus target price of $19.00, suggesting a potential upside of 94.08%. Coupang has a consensus target price of $50.60, suggesting a potential upside of 28.52%. Given Nuvve's stronger consensus rating and higher probable upside, research analysts clearly believe Nuvve is more favorable than Coupang.

Valuation & Earnings

This table compares Nuvve and Coupang's revenue, earnings per share and valuation.

Profitability

This table compares Nuvve and Coupang's net margins, return on equity and return on assets.

Summary

Nuvve beats Coupang on 2 of the 2 factors compared between the two stocks.

Nuvve (NASDAQ:NVVE) and ContextLogic (NASDAQ:WISH) are both consumer cyclical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Profitability

This table compares Nuvve and ContextLogic's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent recommendations for Nuvve and ContextLogic, as reported by MarketBeat.

Nuvve currently has a consensus price target of $19.00, suggesting a potential upside of 94.08%. ContextLogic has a consensus price target of $24.0769, suggesting a potential upside of 87.37%. Given Nuvve's stronger consensus rating and higher possible upside, equities research analysts plainly believe Nuvve is more favorable than ContextLogic.

Valuation and Earnings

This table compares Nuvve and ContextLogic's gross revenue, earnings per share and valuation.

Summary

Nuvve beats ContextLogic on 2 of the 3 factors compared between the two stocks.

Travel + Leisure (NYSE:TNL) and Nuvve (NASDAQ:NVVE) are both consumer cyclical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends.

Analyst Ratings

This is a summary of current recommendations for Travel + Leisure and Nuvve, as provided by MarketBeat.com.

Travel + Leisure currently has a consensus target price of $76.00, indicating a potential upside of 16.92%. Nuvve has a consensus target price of $19.00, indicating a potential upside of 94.08%. Given Nuvve's higher possible upside, analysts plainly believe Nuvve is more favorable than Travel + Leisure.

Valuation & Earnings

This table compares Travel + Leisure and Nuvve's top-line revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Travel + Leisure and Nuvve's net margins, return on equity and return on assets.

Nuvve (NASDAQ:NVVE) and Petco Health and Wellness (NASDAQ:WOOF) are both consumer cyclical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability and earnings.

Earnings & Valuation

This table compares Nuvve and Petco Health and Wellness' gross revenue, earnings per share (EPS) and valuation.

Insider and Institutional Ownership

76.5% of Petco Health and Wellness shares are owned by institutional investors. 4.6% of Petco Health and Wellness shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Nuvve and Petco Health and Wellness' net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Nuvve and Petco Health and Wellness, as reported by MarketBeat.com.

Nuvve presently has a consensus price target of $19.00, suggesting a potential upside of 94.08%. Petco Health and Wellness has a consensus price target of $29.1111, suggesting a potential upside of 20.49%. Given Nuvve's stronger consensus rating and higher possible upside, research analysts plainly believe Nuvve is more favorable than Petco Health and Wellness.

Summary

Petco Health and Wellness beats Nuvve on 3 of the 5 factors compared between the two stocks.

Diversey (NASDAQ:DSEY) and Nuvve (NASDAQ:NVVE) are both consumer cyclical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, analyst recommendations and earnings.

Valuation and Earnings

This table compares Diversey and Nuvve's gross revenue, earnings per share and valuation.

Profitability

This table compares Diversey and Nuvve's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Diversey and Nuvve, as reported by MarketBeat.com.

Diversey presently has a consensus price target of $18.6667, suggesting a potential upside of 6.18%. Nuvve has a consensus price target of $19.00, suggesting a potential upside of 94.08%. Given Nuvve's stronger consensus rating and higher possible upside, analysts plainly believe Nuvve is more favorable than Diversey.

Summary

Nuvve beats Diversey on 2 of the 3 factors compared between the two stocks.

Nuvve (NASDAQ:NVVE) and Yatsen (NYSE:YSG) are both consumer cyclical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Profitability

This table compares Nuvve and Yatsen's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of current recommendations for Nuvve and Yatsen, as reported by MarketBeat.

Nuvve currently has a consensus target price of $19.00, suggesting a potential upside of 94.08%. Yatsen has a consensus target price of $20.30, suggesting a potential upside of 106.09%. Given Yatsen's higher possible upside, analysts plainly believe Yatsen is more favorable than Nuvve.

Earnings and Valuation

This table compares Nuvve and Yatsen's gross revenue, earnings per share (EPS) and valuation.

Summary

Yatsen beats Nuvve on 2 of the 3 factors compared between the two stocks.